In vitro release of eosinophil cationic protein from peripheral eosinophils reflects disease activity in childhood Crohn disease and ulcerative colitis

European Journal of Pediatrics

Volumn 156, Issue 12, 1997, Pages 921-924

  Luck, W ^a   Becker, M ^a   Niggemann, B ^a   Wahn, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Crohn disease; Disease activity indices; Eosinophil cationic protein; Eosinophils; Ulcerative colitis

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; OROSOMUCOID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CROHN DISEASE; DISEASE COURSE; EOSINOPHIL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; ULCERATIVE COLITIS;

ADOLESCENT; BLOOD PROTEINS; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; RIBONUCLEASES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0031438841     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050743     Document Type: Article

References (24)

1. Axen R, Drevin H, Koher A, Ymaon L (1988) A new laboratory diagnostic system applied to allergy testing. N Engl Reg Allergy Proc 9:503 (Abstract)
2. Balfour Sartor R (1994) Cytokines in intestinal inflammation Pathophysiological and clinical considerations. Gastroenterology 106:533-539
3. Berstad A, Borkje B, Riedel B, Elsayed S, Berstadt (1993) Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepatogastroenterology 40:276-278
4. Blom M, Tool ATJ, Kok PTM, Koenderman L, Roos D, Verhoeven AJ (1994) Granulocyte-Macrophage Colony-stimulating factor, Interleukin-3 IL-3), and IL-5 greatly enhance the interaction of human eosinophils with opsonized particles by changing the affinity of complement receptor type 3. Blood 83:2978-2984
5. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domitio P, Walker-Smith JA, Mac Donald T (1994) Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenteroloey 106:1455-1466
6. Campbell CA, Walker-Smith JA, Hindocha P, Adinolli M (1982) Acute phase proteins in chronic inflammatory bowel disease in childhood. J Pediatr Gastroenterol Nutr 1:193-200
7. Choy MY, Walker-Smith JA, Williams CB, MacDonald TT (1990) Activated eosinophils in chronic inflammatory bowel disease. Lancet 336:126-127
8. Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, Capron M, Colombel JF (1995) Activated eosinophils and interleukin-5 expression in early recurrence of Crohn's disease. Gut 37:242-246
9. Hällgren R, Colombel JF, Dahl R, et al (1989) Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: Studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. Am J Med 86:56-64
10. Hyams JS, Ferry GD, Mandel FS, Gryboski JB, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Grand RJ, Boyle JT, Michener WM, Levy JS, Lesser ML (1991) Development and validation of a Pediatric Crohn's Disease Activity Index. J Pediatr Gastroenterol Nutr 12:439-447
11. Hyams JS, Mandel F, Ferry GD (1992) Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 14:216-222
12. Kam L, Pizarro TT, Cominelli F (1995) Cytokines and chemokines in inflammatory bowel disease. Curr Opin Gastroenterol 11:305-309
13. Koller DY, Urbanek R, Götz M (1995) Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med 152:629-633
14. Macfarlane PI, Miller V, Wells F, Richards B (1986) Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis. J Pediatr Gastroenterol Nutr 5:93-96
15. Mazlam MZ, Hodgson HJF (1994) Interrelations between interleukin-6, interleukin-1β, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut 35:77-83
16. Morson BC (1971) Histopathology. In: Engel A, Larsson T (eds) Regional enteritis Crohn's disease. Skandia International Symposia 5. Nordiska Bokhandelns Förlag. Stockholm, pp 15:33
17. Peterson CGB, Enander I, Nystrand J, Anderson AS, Nilsson L, Venge P (1991) Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 21:561-567
18. Rachmilewitz D (1989) On behalf on an international study group. Coated mesalazine (5-aminosalicilic acid) versus sulphasalazine in the treatment of active UC: a randomised trial. BMJ 298:82-86
19. Robinson DS, Assoufi B, Durham SR, Kay AB (1995) Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy 25:1118-1127
20. Robinson DS, Hamid Q, Sun Ying M (1993) Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell IL-4, IL-5 and IFN-γ cytokine gene expression. Am Rev Respir Dis 148:401-406
21. Schachter H, Kirschner JB (1975) Definitions of inflammatory bowel disease of unknown aetiology. Gastroenterology 68:591-600
22. Stenson WF (1994) Inflammatory mediators in inflammatory bowel disease. Curr Opin Gastroenterol 10:384-389
23. Venge P, Dahl D, Fredens K, Hällgren R, Peterson C. Eosinophil cationic proteins (ECP and EPX) in health and disease (1983) In: Yoshida T, Torisu M (eds) Inimunobiology of the eosinophil. Elsevier. New York, pp 163-179
24. Walsh RE, Gaginella TS (1991) The eosinophil in inflammatory bowel disease. Scand J Gastroenterol 26:1217-1224